Int. J. Mol. Sci. 2012, 13(3), 3549-3562; doi:10.3390/ijms13033549
Article

A Comparative Study on the Expression, Purification and Functional Characterization of Human Adiponectin in Pichia pastoris and Escherichia coli

1email, 2email, 3email and 2,3,* email
Received: 4 January 2012; in revised form: 28 February 2012 / Accepted: 6 March 2012 / Published: 15 March 2012
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Adiponectin is one of the most bioactive substances secreted by adipose tissue and is involved in the protection against metabolic syndrome, artherosclerosis and type II diabetes. Research into the use of adiponectin as a promising drug for metabolic syndromes requires production of this hormone in high quantities considering its molecular isoforms. The objective of this study is to produce recombinant human adiponectin by Pichia pastoris (P-ADP) as a cheap and convenient eukaryotic expression system for potential application in pharmaceutical therapy. For comparison, adiponectin was also expressed using the Escherichia coli (E-ADP) expression system. Adiponectin was constructed by overlap-extension PCR, and cloned in standard cloning vector and hosts. Recombinant expression vectors were cloned in the P. pastoris and E. coli host strains, respectively. SDS-PAGE and western blotting were used to detect and analyse expressed recombinant protein in both systems. Adiponectin was purified by affinity chromatography and quantified using the Bradford Assay. The results of this study indicated that P-ADP quantity (0.111 mg/mL) was higher than that of E-ADP (0.04 mg/mL) and both were produced in soluble form. However, P-ADP was able to form high molecular weights of adiponectin molecules, whilst E-ADP was not able to form isoforms higher than trimer. In addition, P-ADP was more active in lowering blood glucose compared with E-ADP. The two types of proteins were equally efficient and significantly decreased blood triglyceride and increased high density lipoprotein. We conclude that P. pastoris is able to produce high quantity of bioactive adiponectin for potential use in treatment of metabolic syndromes.
Keywords: adiponectin; Pichia pastoris; E.coli; recombinant protein; biological activity
PDF Full-text Download PDF Full-Text [429 KB, Updated Version, uploaded 19 June 2014 04:13 CEST]
The original version is still available [963 KB, uploaded 19 June 2014 04:13 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Rothan, H.A.; Teh, S.H.; Haron, K.; Mohamed, Z. A Comparative Study on the Expression, Purification and Functional Characterization of Human Adiponectin in Pichia pastoris and Escherichia coli . Int. J. Mol. Sci. 2012, 13, 3549-3562.

AMA Style

Rothan HA, Teh SH, Haron K, Mohamed Z. A Comparative Study on the Expression, Purification and Functional Characterization of Human Adiponectin in Pichia pastoris and Escherichia coli . International Journal of Molecular Sciences. 2012; 13(3):3549-3562.

Chicago/Turabian Style

Rothan, Hussin A.; Teh, Ser Huy; Haron, Kamariah; Mohamed, Zulqarnain. 2012. "A Comparative Study on the Expression, Purification and Functional Characterization of Human Adiponectin in Pichia pastoris and Escherichia coli ." Int. J. Mol. Sci. 13, no. 3: 3549-3562.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert